The crystal and molecular structures of four stereoisomers of tapentadol hydrochloride [systematic name: 3-(3-hydroxyphenyl)-N,N,2-trimethylpentan-1-aminium chloride], C 14 H 24 -NO + ÁCl À , a novel analgesic agent, have been determined by X-ray crystal structure analysis. Resolution of the isomers was carried out by reverse-phase and chiral high-performance liquid chromatographic (HPLC) methods. Stereoisomers (I) and (II) crystallize in the monoclinic space group P2 1 , each with two tapentadol cations and two chloride anions in the asymmetric unit, while stereoisomers (III) and (IV) crystallize in the orthorhombic space group P2 1 2 1 2 1 , with one tapentadol cation and one chloride anion in the asymmetric unit. The absolute configurations of the four enantiomers were determined unambiguously by X-ray crystallography. The crystal structures reveal the stereochemistries at the 3-ethyl and 2-methyl groups to be R,R, S,S, S,R and R,S in stereoisomers (I)-(IV), respectively. The ethyl and aminopropyl groups adopt different orientations with respect to the phenol ring for (I) and (IV). In all four structures, the chloride ions take part in N-HÁ Á ÁCl and O-HÁ Á ÁCl hydrogen bonds with the tapentadol molecules, resulting in one-dimensional helical chains in the crystal packing in each case.
Comment
Tapentadol is a novel centrally acting synthetic analgesic with a unique profile of action for the treatment of moderate to severe pain (Tzschentke et al., 2007) . It acts in two ways, viz. opioid (narcotic) and non-opioid. Tapentadol affects the brain and body primarily by activating opioid receptors in the brain, spinal cord and gastrointestinal tract. In addition, it inhibits the re-uptake of the brain chemical norepinephrine which possibly has an analgesic effect. Tapentadol is being developed in immediate-release and extended-release formulations (Etropolski et al., 2010) .
The United States Food and Drug Administration (US FDA) approved tapentadol hydrochloride in 2008 as an immediate-release oral tablet for the relief of moderate to severe acute pain, both cancer-related and other. Tapentadol is manufactured by Janssen Ortho LLC, Gurabo, Puerto Rico, USA, and was initially developed by Grunenthal GmbH, Aachen, Germany, in conjunction with Johnson & Johnson Pharmaceutical Research and Development. We report here the crystal structures of four stereoisomers of tapentadol hydrochloride, (I)-(IV), as part of our ongoing study of the structural characterization of drug molecules (Ravikumar & Sridhar, 2009 .
Resolution of the four isomers was carried out using reverse-phase and chiral high-performance liquid chromatography (HPLC) methods; compounds (I)-(IV) showed good resolution in HPLC analysis and diastereomeric isomer separation in reverse-phase HPLC analysis. The purities of all individual isomers were confirmed by both chiral and reversephase HPLC. In the chiral method, isomers (I), (II), (III) and (IV) eluted at retention times of 19.21, 24.56, 17.81 and 16.61 min, respectively (Fig. 1) , whereas in the reverse-phase method, the retention times were 17.00, 17.21, 15.58 and organic compounds 15.48 min, respectively. It can be seen that isomers (I) and (II) are one pair of enantiomers, and isomers (III) and (IV) are a second pair, having similar retention times in reverse-phase HPLC analysis.
Differential scanning calorimetric (DSC) measurements were carried out using a Perkin-Elmer Diamond DSC apparatus. Experiments were performed at a heating rate of 10.0 K min À1 over a temperature range of 303-533 K under a nitrogen flow of 50 ml min
À1
. The DSC curves for (I)-(IV) show sharp endothermic peaks, corresponding to melting points, at 482, 480, 477 and 478 K for isomers (I)-(IV), respectively (Fig. 2) .
Tapentadol consists of a meta-substituted phenol ring possessing an ethyl and an aminopropyl residue at C7. It has two stereogenic centres, at C7 and C10, which results in four possible diastereomers; the R,R isomer is currently the clinically used form (Franklin et al., 2010) . Tapentadol is structurally the closest chemical relative of tramadol in clinical use. Both tramadol and venlafaxine are racemic mixtures (Reeves & Cox, 2008) , whereas tapentadol represents only one stereoisomer, viz. (1R,2R). Structurally, tapentadol differs from tramadol in being a phenol and not an ether. Also, both tramadol and venlafaxine incorporate a cyclohexyl group attached directly to the aromatic ring, while tapentadol lacks this feature.
The crystal structures of isomers (I) and (II) are enantiomorphs, crystallizing in the space group P2 1 . Similarly, the crystal structures of isomers (III) and (IV) are also enantiomorphs, but crystallizing in the space group P2 1 2 1 2 1 . Thus, (I)/ (III) and (II)/(IV) are pairs of diastereomers. Unambiguous determination of the absolute configurations of all four structures was carried out by means of refinement of the Flack parameter (Flack & Bernardinelli, 2000) . It was therefore assigned that (I) is the R,R enantiomer and (II) is the S,S enantiomer, with melting points of 482-483 and 480-481 K, respectively. It was also found that (III) is the S,R isomer and (IV) is the R,S isomer, with melting points of 477-478 and 478-479 K, respectively, from the above-mentioned DSC studies. Each asymmetric unit in (I) and (II) comprises two tapentadol cations and two chloride anions (Fig. 3) . In the case of (III) and (IV), the asymmetric unit consists of one tapentadol cation and one chloride anion (Fig. 4) .
The geometric parameters of (I)-(IV) are similar. However, there are significant angular variations observed between the two independent molecules of (I) and (II) involving the chiral atom C7, the differences being C7-C8-C9 = 2.5 (2) [in (I)] and 2.7 (2) [in (II)], and C8-C7-C10 = 2.1 (1) [in (I)] and 2.3 (2) [in (II)] (Table 1) . This may perhaps be attributed to the syn/anti conformers found around the C8-C9 bond. The aminopropyl and ethyl groups are located on opposite sides of the plane defined by the aromatic ring. The two cations in asymmetric unit of (I), although constructed from molecules with the same chirality, are paired around a pseudocentre of symmetry at ( 1 4 , 0.65, 3 4 ) and differ significantly in the orientation of atom C9 of the ethyl group. The orientation of the ethyl group with respect to the phenol ring can be seen from the torsion angle C1-C7-C8-C9, which is cis in molecule A of (I) and trans in molecule B, while in (III) it adopts a cis orientation. The conformation of the aminopropyl group can be defined from the C-C-C-C and C-C-C-N torsion angles, and the conformation is cis-trans for both molecules of (I), while it is trans-trans for (III) ( Table 1 ). An overlay of the tapentadol molecules, superimposing atoms C1-C7 of the phenol ring system, reveals the differences in orientation of both the ethyl and aminopropyl groups with respect to the phenol ring (Fig. 5) . It is interesting to note that the ethyl group of (III) adopts a similar conformation to molecule (IA), while the conformation of the aminopropyl group is entirely different from (I). This difference might influence the participation of the aminopropyl group in C-HÁ Á ÁCl interactions in (III), which are absent in (I). Views of (a) (III) and (b) (IV), showing the atom-numbering schemes. Displacement ellipsoids are drawn at the 50% probability level. Dashed lines indicate hydrogen bonds.
Figure 5
Superposition of the molecular conformations of the tapentadol molecules of (I) and (IV), showing the orientations of the ethyl and aminopropyl groups with respect to the phenol ring. The overlay was made by making a least-squares fit through the planar phenol ring (atoms C1-C7) of tapentadol [molecules (IA) and (IB)] and (IV). The crystal structures of the four stereoisomers, (I)-(IV), feature N-HÁ Á ÁCl and O-HÁ Á ÁCl hydrogen bonds (Tables  2-5 ) between the chloride ions and the amino and hydroxy groups of the tapentadol molecules. Each chloride ion accepts two hydrogen bonds from the amino and hydroxy groups of the tapentadol molecules and forms a one-dimensional helical chain. In (I) and (II), the helical chain is along the a axis (Fig. 6) , while in (III) and (IV) it is along the b axis (Fig. 7) . Furthermore, in (III) and (IV) C-HÁ Á ÁCl interactions link the helical chains to adjacent chains.
Experimental
(2R,3R)-3-(3-Hydroxyphenyl)-N,N,2-trimethylpentan-1-aminium chloride, (I), was prepared as follows. (2R,3S)-1-Dimethylamino-3-(3-hydroxyphenyl)-2-methylpentan-3-ol tartaric acid salt (35 g, 1 mol) and water (150 ml) were placed in a round-bottomed flask and an aqueous ammonia solution (30 ml) was added to obtain a basic pH, followed by extraction into dichloromethane (150 ml) at 293-298 K. The organic layer was separated, dried over anhydrous sodium sulfate and concentrated under reduced pressure to afford an oil. 2-Methyltetrahydrofuran (300 ml) and trifluoroacetic anhydride (50 ml) were added to this oil at 293-298 K. The mixture was transferred to an autoclave, Pd/C (9 g, 10% Pd, 50% wet) was added and a hydrogen pressure (5 to 7 kg cm À2 ; 1 kg cm À2 = 98066.5 Pa) was applied. The reaction mixture was heated to 318-323 K for 5 h. After cooling, the reaction mass was filtered through Celite Hyflo Super Cel and the filtrate was distilled under vacuum at 318-323 K to obtain an oil, to which water (150 ml) and aqueous ammonia (30 ml) were added. The aqueous layer was extracted using dichloromethane (150 ml) and the organic layer was separated, dried over anhydrous sodium sulfate and concentrated under vacuum at 308-313 K to obtain an oil. Propan-2-ol (100 ml) and propan-2-ol-HCl (30 ml, pH 1-2) were added to this oil and the mixture stirred for 1 h at 293-298 K. The resulting slurry was cooled to 273-278 K for 1 h. The solid was filtered off and washed with propan-2-ol (30 ml), and then dried in an air oven at 328 K for 10-12 h. The solid was then recrystallized from butanone to yield a white solid. (2S,3S)-3-(3-Hydroxyphenyl)-N,N,2-trimethylpentan-1-aminium chloride, (II), was prepared as follows. Using (2S,3R)-1-dimethylamino-3-(3-hydroxyphenyl)-2-methylpentan-3-ol tartaric acid salt, (25 g, 1 mol), the above process was followed to obtain (II (2R,3S)-3-(3-Hydroxyphenyl)-N,N,2-trimethylpentan-1-aminium chloride, (III), was prepared as follows. Toluene (160 ml), aluminium chloride (45.3 g) and thiourea (20 g) were placed in a roundbottomed flask and stirred at 293-298 K for 30 min. (2R,3S)-1-Dimethylamino-3-(3-methoxyphenyl)-2-methylpentane (20 g, 1 mol) was dissolved in toluene (40 ml). This solution was added to the above mixture at 293-298 K and the combined mixture heated at 383-388 K for 6 h. After cooling, water (50 ml) and aqueous ammonia (100 ml) were added, and the mixture was filtered through Hyflo and the organic layer separated. The aqueous layer was extracted with toluene (100 ml). The combined organic layers were washed with water (100 ml), dried over anhydrous sodium sulfate and concentrated under vacuum at 323-328 K to obtain an oil. Propan-2-ol (50 ml) and propan-2-ol-HCl (30 ml, pH 1-2) were added to this oil and the mixture was stirred for 2 h at 273-278 K. The solid was then filtered off, washed with propan-2-ol (10 ml), dried under vacuum at 313-318 K for 2 h and recrystallized from butanone to yield a white solid (m.p. 477-478 K). (200 g) and aqueous ammonia (200 ml) were added to the reaction mass at 278-283 K. The product was extracted with dichloromethane (400 ml) and the organic layer was separated, dried over anhydrous sodium sulfate and concentrated under vacuum at 308-313 K to obtain an oil. Propan-2-ol (100 ml) and propan-2-olHCl (20 ml, pH 1-2) were added to this oil and the mixture stirred for 2 h at 273-278 K. The solid was then filtered off, washed with propan-2-ol (25 ml), dried in an air oven at 323-328 K and recrystallized from butanone to yield a white solid (m.p. 478-479 K). HPLC analysis was performed with a Shimadzu LC 2010 series HPLC system (EMPOWER software) equipped with a quaternary pump and UV detector monitoring the range 200-400 nm. Isomers were analysed on a CHIRALPAK AD-3 (250 Â 4.6 mm Â 5 mm) column using the normal-phase method, while a reverse-phase HPLC analysis was carried out using INERTSIL ODS-3 V (4.6 Â 250 mm Â 5 mm). The mobile phase was an 85:15 (v/v) mixture of hexane and tetrahydrofuran, respectively.
Single crystals of all four isomers, (I)-(IV), suitable for X-ray crystallography studies were obtained by cooling hot methanol solutions.
Stereoisomer (I)
Crystal data Table 5 Hydrogen-bond geometry (Å , ) for (IV). Hydrogen-bond geometry (Å , ) for (III). Hydrogen-bond geometry (Å , ) for (II). Symmetry code: (i) x þ 1; y; z.
Table 2
Hydrogen-bond geometry (Å , ) for (I). 
Stereoisomer (IV)
Crystal data Á min = À0.13 e Å
À3
Absolute structure: Flack & Bernardinelli (2000) , with 1104 Friedel pairs Flack parameter: 0.00 (6) All N-and O-bound H atoms were located in a difference Fourier density map and refined isotropically. All other H atoms were positioned geometrically and treated as riding on their parent C atoms, with C-H = 0.93-0.98 Å , and with U iso (H) = 1.5U eq (C) for methyl or 1.2U eq (C) for other H atoms. The methyl groups were allowed to rotate but not to tip.
For all compounds, data collection: SMART (Bruker, 2001 ); cell refinement: SAINT (Bruker, 2001 ); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: DIAMOND (Brandenburg & Putz, 2005) , PLATON (Spek, 2009) and Mercury (Macrae et al., 2008) ; software used to prepare material for publication: SHELXL97.
